Trial
NCT01750762
Lenalidomide After Allo Transplant
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Beth Israel Deaconess Medical Center
Collaborators
—
Condition
Multiple Myeloma
Intervention
Lenalidomide
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-04-18